Intensity Therapeutics
INTS
17 hedge funds and large institutions have $8.49M invested in Intensity Therapeutics in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 5 closing their positions.
700% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 1
93% more capital invested
Capital invested by funds: $4.39M → $8.49M (+$4.1M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
8.17% more ownership
Funds ownership: 3.74% → 11.91% (+8.2%)
6% more funds holding
Funds holding: 16 → 17 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sapient Capital
Indianapolis,
Indiana
|
+$3.89M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$755K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$451K |
| 4 |
OCPWS
One Charles Private Wealth Services
Hingham,
Massachusetts
|
+$152K |
| 5 |
BW
Bison Wealth
Atlanta,
Georgia
|
+$83.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HWM
Hohimer Wealth Management
Seattle,
Washington
|
-$384K |
| 2 |
HF
HRT Financial
New York
|
-$273K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$34.3K |
| 4 |
GWS
Glassman Wealth Services
Vienna,
Virginia
|
-$1.71K |
| 5 |
BlackRock
New York
|
-$1.32K |
INTS Hedge Fund Activity: Q1 2024 in Review
17 of the 6,961 institutional investors tracked by Wall St. Rank reported a position in Intensity Therapeutics (INTS) for Q1 2024, worth a combined $8.49M — up 93% from $4.39M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new INTS positions and 5 closed out — a net gain of 1 holder — while 8 added to existing stakes and 1 trimmed.
The largest buyer was Sapient Capital, adding an estimated $3.89M. The largest seller was Hohimer Wealth Management, exiting entirely with an estimated $384K sold.
- 17 institutional investors held Intensity Therapeutics (INTS) as of Q1 2024, up from 16 in Q4 2023.
- Funds reported $8.49M of Intensity Therapeutics stock for Q1 2024, up 93% quarter-over-quarter.
- 6 funds opened new Intensity Therapeutics positions in Q1 2024 and 5 closed out, a net change of +1 holder.
- The largest Intensity Therapeutics buyer in Q1 2024 was Sapient Capital, an estimated $3.89M added.
- The largest Intensity Therapeutics seller in Q1 2024 was Hohimer Wealth Management, an estimated $384K sold.
Based on aggregated 13F filings for Q1 2024.